CCL19 and cancer: In this pathway, we have also found a downregulation of CCL19, a tumor suppressor that reduces proliferation, migration and invasion in gastric cancer (92), and NR0B2, whose downregulation in renal carcinoma is associated with development and progression of cancer (93).